Comprehensive Theranostics Center
BAMF Health is a state-of-the-art, comprehensive Theranostics center delivering the most advanced molecular imaging and radioligand therapy along with novel radiopharmaceutical clinical trials. Our intelligence-based precision medicine approach achieves better results, in less time, with fewer side effects.
Patient Services at BAMF Health
Whether you’re ordering imaging or referring a patient for treatment or clinical trials at BAMF Health, we serve as your reliable partner in delivering high-quality, patient-centered care. Our team ensures rapid scheduling, consistent and timely communication, and full transparency, so you’re informed and involved at every step.
Refer patients for radioligand therapy for metastatic prostate cancer and neuroendocrine tumors.
We are a one-stop shop for MCI consultations, amyloid imaging, and treatment infusions.
Refer patients for imaging and therapy clinical trials for cancer and more.
Patients Come First. Always.
We are uncompromising when it comes to patient care. Our uniquely high patient satisfaction scores reflect our commitment to personalized, compassionate care. Every patient is treated as an individual, not a number. You can trust your patient will receive exceptional attention during their time with us and leave feeling confident, cared for, and understood. Patients can expect:
- Fast scheduling, scans, and results
- Complimentary valet parking
- The most advanced imaging technology
- Private treatment rooms with natural light
-
Our patients don’t like BAMF, they love BAMF. We want to send all of our MRIs and CT scans to BAMF going forward.
Primary Care Provider -
Quality scans, responsive team, and availability of therapeutic options for widely metastatic prostate cancer not available elsewhere.
Division Chief, Radiation Oncology -
I’ve known Dr. Mancini as an excellent radiation oncologist, and having good services close to home for my patients counts a lot.
Thoracic and CI Malignancies Provider -
It's been a genuine pleasure working with you. I really appreciate how well you take care of my patients.
Director, Prostate Cancer Research
Need access to BAMF Health's PACS?
Click the button to get started.
Some of Our Referral Partners
Some of Our In-Network Insurance Providers
Molecular Imaging Clinic
Our Molecular Imaging Clinic is equipped with two of the world’s most advanced scanners including the United States’ first clinical total-body PET/CT and Michigan’s first and only PET/MR.
The uEXPLORER® PET/CT has 2x the resolution of traditional scanners and is 40x more sensitive.
Our uPMR 790 3T PET/MR can acquire hybrid images while significantly reducing radiation exposure. It can also perform a whole-body MR scan in just one hour.
At BAMF Health, we are your source for amyloid imaging for Alzheimer’s Disease. We perform patients’ baseline MR and amyloid PET scans, and we are the only site in Michigan where patients can receive both scans on the same day.
Molecular Therapy Clinic
In our Molecular Therapy Clinic, we deliver the most cutting-edge therapies with skill, precision, and care. Right now, we offer FDA-approved therapies for the treatment of metastatic castration resistant prostate cancer and neuroendocrine tumors.
PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) is indicated for the treatment of adults with PSMA-positive metastatic castration resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibition (APRI) therapy, and:
- are considered appropriate to delay taxane-based chemotherapy, or
- have received prior taxane-based chemotherapy
Common side effects include fatigue, dry mouth, nausea, decreased appetite, anemia, and constipation, with serious risks including myelosuppression, renal toxicity, and radiation exposure to others.
LUTATHERA® (lutetium Lu 177 dotatate) is used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin, including GEP-NETs in the foregut, midgut, and hindgut. Common side effects include nausea, vomiting, fatigue, anemia, thrombocytopenia, and increased liver enzymes; serious risks include myelosuppression, renal toxicity, and secondary myelodysplastic syndrome or leukemia.
Our Latest News
Join the BAMF Health 108 Walk for Prostate Cancer
Join us this September as we raise awareness for prostate cancer by walking 108 miles!
August 18, 2025
BAMF Health, Ferris State, KentISD expand partnership to accelerate high schoolers’ path toward innovative STEM careers
Enrollment for this year’s FutureSolve program is nearly double last year’s.
July 6, 2025
BAMF Health Launches National Clinical Trials Platform, BAMF RadioNexus, and Enrolls National Health System
RadioNexus is the world’s first radiopharmaceutical-focused clinical trials network.
June 18, 2025